1-8 of 8
Esther Bachar-Lustig, PhD
Close
Sort by
Journal Articles

Towards Safer Allogeneic HSCT in Autoimmunity: Proof of Concept in Diabetes-Prone Mice

Rakefet Sidlik Muskatel, MD, Bar Nathansohn-Levi, PhD, Esther BACHAR Lustig, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3212.
https://doi.org/10.1182/blood-2019-124905
Published: 2019
Journal Articles

Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells

Aloukick Kumar Singh, PhD, Elias Schetzen, PhD, Esther BACHAR Lustig, PhD, Wei-Hsin Liu, M.Sc, Raj Kumar Yadav, PhD, Sandeep Kumar Yadav, PhD, Kathryn McGinnis, M.Sc, Yair Reisner, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1919.
https://doi.org/10.1182/blood-2019-124594
Published: 2019
Journal Articles

High Levels of Hematopoietic Progenitors in the Fetal Lung Enable Induction of Immune Tolerance and Co-Transplantation of Epithelial Progenitors for Repair of Lung Injury Across MHC Barriers

Carmit Hillel Karniel, MSc, Chava Rosen, MD PhD, Esther Bachar Lustig, PhD, Elias Shezen, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2016) 128 (22): 1477.
https://doi.org/10.1182/blood.V128.22.1477.1477
Published: 2016
Journal Articles

Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity

Esther Bachar Lustig, PhD, Noga Or Geva, PhD, Assaf Lask, PhD, Rotem Gidron, MD, Sivan Kagan, PhD, Aloukick Kumar Sinqh, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2016) 128 (22): 3345.
https://doi.org/10.1182/blood.V128.22.3345.3345
Published: 2016
Journal Articles

Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT

Esther Bachar-Lustig, PhD, Noga Or-Geva, MSc, Yael Zlotnikov Klionsky, MSc, Yair Reisner, PhD
Journal: Blood
Blood (2013) 122 (21): 3238.
https://doi.org/10.1182/blood.V122.21.3238.3238
Published: 2013
Journal Articles

Towards Clinically Feasible Co-Stimulatory Blockade for Tolerance Induction: Transient Treatment with CTLA4-Ig, Anti-CD48 and FTY720 Enables Durable Engraftment of T Cell Depleted BM Allografts Following Non-Myeloablative Conditioning.

Esther Bachar-Lustig, PhD, Dalit Tchorsh-Yutsis, PhD, Eran Ophir, MSc, Yael Zlotnikov Klionsky, MSc, Noga Or-Geva, BSc, Yair Reisner, PhD
Journal: Blood
Blood (2010) 116 (21): 3726.
https://doi.org/10.1182/blood.V116.21.3726.3726
Published: 2010
Journal Articles

Overcoming Rejection of Bone Marrow Allografts by Treg Cells in a Stringent Mouse Model for T Cell Mediated Rejection: Tolerance Induction by Third Party “Off-the-Shelf” Cells.

David Steiner, PhD, Noga Brunicki, MSc, Esther Bachar-Lustig, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2005) 106 (11): 576.
https://doi.org/10.1182/blood.V106.11.576.576
Published: 2005
Journal Articles

Effective Deletion of Anti-Donor Host Memory Effector Cells by Anti-3rd Party Veto CTLs: Implications to Tolerance Induction in Presensitized Bone Marrow Recipients.

Shlomit Reich-Zeliger, PhD, Esther Bachar-Lustig, PhD, Yair Reisner, PhD
Journal: Blood
Blood (2004) 104 (11): 44.
https://doi.org/10.1182/blood.V104.11.44.44
Published: 2004